glp-1 agonist and dpp-4 inhibitor dpp-4_inhibitors [TUSOM DPP-4 inhibitors and GLP-1RAs: cardiovascular
Description
Tirzepatide is the first in a class of drugs called dual GLP-1/GIP receptor agonists that activate the receptor for another gut hormone, glucose-dependent insulinotropic polypeptide (GIP), in addition to the GLP-1 receptor
Animal and clinical studies have shown that GLP-1RAs ameliorate liver inflammation and lower the risk of NAFLD and NASH developing into liver cancer
10.4158/EP09104.CRR 7 BabajideO.NabinK
The case raises a question that researchers are now actively investigating
Danuglipron Danuglipron is another oral, non-peptide, G-protein biased GLP-1 RA [26]
Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in alzheimers disease
